Stelac Advisory Services’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Stelac Advisory Services’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-140,402	Closed	-$101K	–	114
2024 Q1	$101K	Buy	+140,402	New	+$102K	0.05%	105

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Stelac Advisory Services's VAXX Position: Q2 2024 in Review

Stelac Advisory Services sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 140,402 shares — an estimated $101K sold.

Stelac Advisory Services first reported a position in VAXX in Q1 2024 and held it in 1 quarter. The position peaked at $101K in Q1 2024. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Stelac Advisory Services reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Stelac Advisory Services sold 140,402 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $101K.
Stelac Advisory Services first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2024 and held it in 1 quarter.
Stelac Advisory Services's Vaxxinity, Inc. Class A Common Stock position peaked at $101K in Q1 2024.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Stelac Advisory Services's 13F filing for Q2 2024, filed 29 Jul 2024.